ArticleScientific reports2025

Targeting asparagine and cysteine in SARS-CoV-2 variants and human pro-inflammatory mediators to alleviate COVID-19 severity; a cross-section and in-silico study.

Hewida H Fadel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.